We/PRP study/VBP the/DT problem/NN of/IN learning/NN to/TO choose/VB from/IN m/NN discrete/JJ treatment/NN options/NNS (/-LRB- e.g./FW ,/, medical/JJ drugs/NNS )/-RRB- the/DT one/NN with/IN best/JJS causal/JJ effect/NN for/IN a/DT particular/JJ instance/NN (/-LRB- e.g./FW ,/, patient/NN )/-RRB- characterized/VBN by/IN an/DT observation/NN of/IN covariates/NNS ./.
The/DT training/NN data/NNS consists/VBZ of/IN observations/NNS of/IN covariates/NNS ,/, treatment/NN ,/, and/CC the/DT outcome/NN of/IN the/DT treatment/NN ./.
We/PRP recast/VBP the/DT problem/NN of/IN learning/NN to/IN personalize/VB from/IN these/DT observational/JJ data/NNS as/IN a/DT single/JJ learning/NN task/NN ,/, which/WDT we/PRP use/VBP to/TO develop/VB four/CD specific/JJ machine/NN learning/NN methods/NNS to/TO directly/RB address/VB the/DT personalization/NN problem/NN ,/, two/CD with/IN a/DT unique/JJ interpretability/NN property/NN ./.
We/PRP also/RB show/VBP how/WRB to/TO validate/VB personalization/NN models/NNS on/IN observational/JJ data/NNS ,/, proposing/VBG the/DT new/JJ coefficient/NN of/IN personalization/NN as/IN a/DT unitless/JJ measure/NN of/IN effectiveness/NN ./.
We/PRP demonstrate/VBP the/DT power/NN of/IN the/DT new/JJ methods/NNS in/IN two/CD specific/JJ personalized/JJ medicine/NN and/CC policymaking/NN applications/NNS and/CC show/VBP they/PRP provide/VB a/DT significant/JJ advantage/NN over/IN standard/JJ approaches/NNS ./.
